CN100340287C - 防止uvb引起的皮肤损伤的方法 - Google Patents

防止uvb引起的皮肤损伤的方法 Download PDF

Info

Publication number
CN100340287C
CN100340287C CNB028112849A CN02811284A CN100340287C CN 100340287 C CN100340287 C CN 100340287C CN B028112849 A CNB028112849 A CN B028112849A CN 02811284 A CN02811284 A CN 02811284A CN 100340287 C CN100340287 C CN 100340287C
Authority
CN
China
Prior art keywords
tsp
cell
skin
uvb
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB028112849A
Other languages
English (en)
Chinese (zh)
Other versions
CN1512868A (zh
Inventor
迈克尔·J·德特马
矢野喜一郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of CN1512868A publication Critical patent/CN1512868A/zh
Application granted granted Critical
Publication of CN100340287C publication Critical patent/CN100340287C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB028112849A 2001-04-13 2002-04-11 防止uvb引起的皮肤损伤的方法 Expired - Lifetime CN100340287C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28387401P 2001-04-13 2001-04-13
US60/283,874 2001-04-13

Publications (2)

Publication Number Publication Date
CN1512868A CN1512868A (zh) 2004-07-14
CN100340287C true CN100340287C (zh) 2007-10-03

Family

ID=23087934

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028112849A Expired - Lifetime CN100340287C (zh) 2001-04-13 2002-04-11 防止uvb引起的皮肤损伤的方法

Country Status (8)

Country Link
US (1) US6712617B2 (cg-RX-API-DMAC7.html)
EP (1) EP1377253A4 (cg-RX-API-DMAC7.html)
JP (1) JP2004526758A (cg-RX-API-DMAC7.html)
KR (2) KR20040021598A (cg-RX-API-DMAC7.html)
CN (1) CN100340287C (cg-RX-API-DMAC7.html)
CA (1) CA2446093A1 (cg-RX-API-DMAC7.html)
TW (1) TWI233361B (cg-RX-API-DMAC7.html)
WO (1) WO2002083088A1 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266706A1 (en) * 2002-11-05 2004-12-30 Muthiah Manoharan Cross-linked oligomeric compounds and their use in gene modulation
TWI312681B (en) * 2001-02-01 2009-08-01 Novel physiologically active substance
TWI334866B (en) * 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
US7238370B2 (en) * 2002-06-14 2007-07-03 Rosenberg E William Method and composition to prevent and treat photoaging of skin
JP5122060B2 (ja) * 2002-06-25 2013-01-16 株式会社 資生堂 抗老化剤
US7256178B2 (en) * 2002-07-31 2007-08-14 Eisai Co., Ltd. Physiologically active substances
EP1541570A4 (en) * 2002-07-31 2008-05-21 Mercian Corp NEW PHYSIOLOGICALLY EFFECTIVE SUBSTANCE
US7458982B2 (en) 2002-10-04 2008-12-02 Photokinetix, Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
DE10254214A1 (de) * 2002-11-20 2004-06-09 Beiersdorf Ag Oligoribonukleotide zur Behandlung von degenerativen Hauterscheinungen durch RNA-Interferenz
RU2330069C2 (ru) * 2002-11-29 2008-07-27 Мершан Корпорейшн Способ получения макролидного соединения и штаммы streptomyces sp., mortierella sp. и micromonosporaceae
US20050281761A1 (en) * 2004-04-01 2005-12-22 Michael Detmar Methods of preventing UVB-induced skin damage
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
US8795315B2 (en) * 2004-10-06 2014-08-05 Cook Medical Technologies Llc Emboli capturing device having a coil and method for capturing emboli
KR101160765B1 (ko) 2004-10-12 2012-06-28 어웨어, 인크. 트랜시버에서의 메모리 할당 방법
CA2607142C (en) * 2005-05-05 2014-03-25 Genencor International, Inc. Personal care compositions and methods for their use
EP1938827A4 (en) * 2005-09-16 2010-07-21 Shiseido Co Ltd NEW HEMMER OF THE EXPRESSION OF VASCULAR ENDOTHEL GROWTH FACTOR
DE602007008365D1 (de) 2006-01-18 2010-09-23 Gen Hospital Corp Verfahren zur steigerung der lymphatischen funktion
EP2005674B1 (en) 2006-04-12 2016-09-28 TQ Delta, LLC Packet retransmission and memory sharing
US20080119433A1 (en) * 2006-07-06 2008-05-22 Aaron Thomas Tabor Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance
CA2659562A1 (en) * 2006-08-14 2008-02-21 Eisai R&D Management Co., Ltd. Stable lyophilized preparation
NZ575828A (en) * 2007-01-29 2011-04-29 Eisai R&D Man Co Ltd Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same
TW200918099A (en) 2007-09-14 2009-05-01 Nitto Denko Corp Drug carriers
US9132202B2 (en) 2009-07-17 2015-09-15 Aaron T. Tabor Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
EP2484359B1 (en) 2009-09-30 2018-07-25 Shiseido Company, Ltd. Heparanase activity inhibitor
JP2023512423A (ja) 2019-12-24 2023-03-27 ジュベナ・セラピューティクス・インコーポレイテッド 再生性ポリペプチドおよびその使用
WO2021133858A1 (en) * 2019-12-24 2021-07-01 Juvena Therapeutics, Inc. Heparin-associated polypeptides and uses thereof
CN117999278A (zh) 2021-06-21 2024-05-07 裘美娜治疗公司 再生性多肽及其用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1258198A (zh) * 1997-05-27 2000-06-28 塞姆柏奥希斯遗传学公司 油体的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US6372234B1 (en) * 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
AU1597199A (en) * 1997-11-25 1999-06-15 Cornell Research Foundation Inc. Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity
KR20010105403A (ko) 1999-03-31 2001-11-28 마빈 씨. 구트리 트롬보스폰딘-2 및 이의 용도
US6673843B2 (en) * 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1258198A (zh) * 1997-05-27 2000-06-28 塞姆柏奥希斯遗传学公司 油体的用途

Also Published As

Publication number Publication date
CN1512868A (zh) 2004-07-14
WO2002083088A1 (en) 2002-10-24
US6712617B2 (en) 2004-03-30
TWI233361B (en) 2005-06-01
EP1377253A4 (en) 2008-09-03
JP2004526758A (ja) 2004-09-02
EP1377253A1 (en) 2004-01-07
KR20080108366A (ko) 2008-12-12
KR20040021598A (ko) 2004-03-10
US20030008821A1 (en) 2003-01-09
CA2446093A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
CN100340287C (zh) 防止uvb引起的皮肤损伤的方法
Zhao et al. Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice
US10517932B2 (en) Compositions and uses thereof
van den Berg et al. Pathogenesis of joint damage in rheumatoid arthritis: evidence of a dominant role for interleukin-1
CN1355881A (zh) 生长分化因子抑制剂及其用途
CN1346370A (zh) 与免疫应答有关的新颖多肽
CN1449445A (zh) Ev－vegf核酸和多肽及使用方法
CN101980603A (zh) LINGO-1和TrkB拮抗剂的用途
CN1145636A (zh) 血管内皮生长因子2
CN113563478A (zh) 白介素-4受体结合融合蛋白及其应用
TW200829267A (en) Method of treating endothelial dysfunction
TW200427472A (en) Device comprising VGF polypeptides
US7772204B1 (en) Perlecan and growth factor for wound and cutaneous injury healing
CN1300367A (zh) 用于类风湿性关节炎诊断的方法和组合物
US20150025452A1 (en) Methods for Modulating Hair Growth Using Truncated Laminin-511
Li et al. Administration of a mutated myostatin propeptide to neonatal mice significantly enhances skeletal muscle growth
KR20070046064A (ko) 피부 손상 방지
CN101300346A (zh) 新型生理物质nesfatin及其相关物质、以及它们的用途
Porst et al. Fibrillin-1 regulates mesangial cell attachment, spreading, migration and proliferation
EP1390060A2 (en) Use of lp82 to treat body weight disorders
AU2002254588B2 (en) Methods of Preventing UVB-Induced Skin Damage
CN100551437C (zh) 附睾特异的抗菌肽Bin1b在精子成熟方面的用途
CN104888221B (zh) 一种治疗皮肤萎缩相关疾病的药物作用靶点
JP2011012045A (ja) 色素幹細胞の未分化性維持促進剤
AU2002254588A1 (en) Methods of Preventing UVB-Induced Skin Damage

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20071003

CX01 Expiry of patent term